Necrotizing enterocolitis is one of the most severe complications in very preterm infants, but there are currently no accepted methods to prevent NEC. Studies have shown that erythropoietin has the potential to prevent NEC or improve outcomes of preterm NEC. This study aimed to determine whether recombinant human EPO could protect against NEC in very preterm infants.
|